Pharma-Bio Serv (PBSV) Cash from Operations (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Cash from Operations of 365311.0 for Q2 2026, down 21.13% year-over-year from 463171.51 in Q2 2025, and up 6.36% on a QoQ basis from 390139.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Cash from Operations (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Cash from Operations history runs 17 years deep, the most recent figure standing at 365311.0 for Q2 2026.
- Cash from Operations for Q2 2026 came in at 365311.0, down 21.13% year-over-year; the trailing twelve-month figure through Apr 2026 was 239260.0 (up 81.92% YoY), and the FY2025 annual result was 214886.0, up 62.08% from the prior year.
- Cash from Operations came in at 365311.0 for Q2 2026 at Pharma-Bio Serv, up from 390139.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1105853.0 in Q3 2022 to a low of 700744.0 in Q2 2024.
- A 5-year average of 52576.67 and a median of 85841.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations surged 367.68% in 2023 and plunged 180.18% in 2024, its largest moves.
- Over 5 years, Cash from Operations stood at 260091.0 in 2022, then advanced by 18.59% to 308436.0 in 2023, then plunged by 74.57% to 78425.0 in 2024, then surged by 256.6% to 279666.0 in 2025, then slumped by 230.62% to 365311.0 in 2026.
- The last three Cash from Operations figures came in at 365311.0 (Q2 2026), 390139.0 (Q1 2026), and 279666.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.13 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 122.94 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 97.53 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 43.08 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 26.12 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 109.52 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 84.91 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -49.47 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 54.50 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | -365,311.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -365,311.00 |
| Apr 30, 2026 | -365,311.00 |
| Jan 31, 2026 | -390,139.00 |
| Jan 31, 2026 | -390,139.00 |
| Oct 31, 2025 | 279,666.00 |
| Oct 31, 2025 | 279,666.00 |
| Jul 31, 2025 | 236,524.00 |
| Jul 31, 2025 | 236,524.00 |
| Apr 30, 2025 | -301,590.00 |
| Apr 30, 2025 | -301,590.00 |
| Jan 31, 2025 | -429,486.00 |
| Jan 31, 2025 | -429,486.00 |
| Oct 31, 2024 | 78,425.00 |
| Oct 31, 2024 | 78,425.00 |
| Jul 31, 2024 | -670,327.00 |
| Jul 31, 2024 | -670,327.00 |
| Apr 30, 2024 | -700,744.00 |
| Apr 30, 2024 | -700,744.00 |
| Jan 31, 2024 | 725,945.00 |
| Jan 31, 2024 | 725,945.00 |